1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- Celularity Inc.
- Gamida Cell Ltd.
- Nohla Therapeutics, Inc.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Cancer is one of the most common causes of deaths across the world. The high prevalence of various types of cancer, such as breast cancer, bladder cancer, lung cancer, leukemia, pancreatic cancer, and prostate cancer, has increased the mortality rate across the world. Countries such as Hungary, Netherlands, Denmark, and Croatia have witnessed an increase in the number of cancer cases over the past few years. The growing instances of cancer-related morbidity across the world will fuel the demand for cancer stem cell therapeutics and drive the growth of the global cancer stem cell therapy market size at a CAGR of over 11% during the forecast period.
Market Overview
Strong drug pipeline
The prevalence of cancer across the world is driving many vendors in the market to develop novel stem cell therapies. Several drugs are in the late stages of clinical trials and are expected to receive marketing approvals over the forecast period. For instance, CanStem 303C is an orally administered drug developed to inhibit cancer cell pathways in patients with metastatic pancreatic ductal adenocarcinoma. The drug is currently in Phase III of clinical trials and is expected to be launched in the US by 2021.
Side-effects of stem cell transplant
Stem cell transplant causes several immediate side effects such as fatigue, vomiting, low levels of platelets and red blood cells, and diarrhea. It may also cause several long term effects such as infertility, eye disorders, early menopause, lung and bone damage, and risk of developing other cancer types. These risk factors may hinder the growth of the global cancer stem cell therapy market size.
Competitive Landscape
The market appears to be fairly concentrated with few players occupying the market share. Companies such as Cellerant Therapeutics Inc. and Celularity Inc. have intensified competition. Factors such as the rising prevalence of cancer and the strong drug pipeline will provide significant growth opportunities for cancer stem cell therapy companies. Cellerant Therapeutics Inc., Celularity Inc., Gamida Cell Ltd., Nohla Therapeutics Inc., and Sumitomo Dainippon Pharma Co. Ltd. are some of the major companies covered in this report.
Market Overview
Strong drug pipeline
The prevalence of cancer across the world is driving many vendors in the market to develop novel stem cell therapies. Several drugs are in the late stages of clinical trials and are expected to receive marketing approvals over the forecast period. For instance, CanStem 303C is an orally administered drug developed to inhibit cancer cell pathways in patients with metastatic pancreatic ductal adenocarcinoma. The drug is currently in Phase III of clinical trials and is expected to be launched in the US by 2021.
Side-effects of stem cell transplant
Stem cell transplant causes several immediate side effects such as fatigue, vomiting, low levels of platelets and red blood cells, and diarrhea. It may also cause several long term effects such as infertility, eye disorders, early menopause, lung and bone damage, and risk of developing other cancer types. These risk factors may hinder the growth of the global cancer stem cell therapy market size.
Competitive Landscape
The market appears to be fairly concentrated with few players occupying the market share. Companies such as Cellerant Therapeutics Inc. and Celularity Inc. have intensified competition. Factors such as the rising prevalence of cancer and the strong drug pipeline will provide significant growth opportunities for cancer stem cell therapy companies. Cellerant Therapeutics Inc., Celularity Inc., Gamida Cell Ltd., Nohla Therapeutics Inc., and Sumitomo Dainippon Pharma Co. Ltd. are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Celularity Inc.
- Gamida Cell Ltd.
- Nohla Therapeutics, Inc.
PART 01: EXECUTIVE SUMMARYPART 07: CUSTOMER LANDSCAPEPART 09: DECISION FRAMEWORK
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY TYPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
List of Exhibits:
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Celularity Inc.
- Gamida Cell Ltd.
- Nohla Therapeutics, Inc.
The following companies are recognised as the key players in the global cancer stem cell therapy market: Cellerant Therapeutics Inc., Celularity Inc., Gamida Cell Ltd., Nohla Therapeutics Inc., and Sumitomo Dainippon Pharma Co. Ltd.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing research activity on cancer stem cell key signaling pathways.”
According to the report, one of the major drivers for this market is the rising prevalence of cancer.
Further, the report states that one of the major factors hindering the growth of this market is the side-effects of stem cell transplant.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing research activity on cancer stem cell key signaling pathways.”
According to the report, one of the major drivers for this market is the rising prevalence of cancer.
Further, the report states that one of the major factors hindering the growth of this market is the side-effects of stem cell transplant.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Cellerant Therapeutics, Inc.
- Celularity Inc.
- Gamida Cell Ltd.
- Nohla Therapeutics, Inc.
- Sumitomo Dainippon Pharma Co. Ltd.
Note: Product cover images may vary from those shown